BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27432118)

  • 1. Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer.
    Li X; Guo J; Ding AP; Qi WW; Zhang PH; Lv J; Qiu WS; Sun ZQ
    Technol Cancer Res Treat; 2017 Aug; 16(4):428-434. PubMed ID: 27432118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
    Colbert LE; Fisher SB; Hardy CW; Hall WA; Saka B; Shelton JW; Petrova AV; Warren MD; Pantazides BG; Gandhi K; Kowalski J; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Curran WJ; Landry JC; Maithel SK; Yu DS
    Cancer; 2013 Sep; 119(17):3148-55. PubMed ID: 23720157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
    Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
    Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer.
    Ruan J; Mei L; Zhu Q; Shi G; Wang H
    Int J Clin Exp Pathol; 2015; 8(11):15035-8. PubMed ID: 26823841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and prognostic value of Nek2 protein expression in colon cancer.
    Lu L; Zhai X; Yuan R
    Int J Clin Exp Pathol; 2015; 8(11):15467-73. PubMed ID: 26823916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer.
    de Oca J; Azuara D; Sanchez-Santos R; Navarro M; Capella G; Moreno V; Sola A; Hotter G; Biondo S; Osorio A; Martí-Ragué J; Rafecas A
    Int J Colorectal Dis; 2008 Jan; 23(1):21-7. PubMed ID: 17805550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients.
    He L; Peng K; Liu Y; Xiong J; Zhu FF
    Onco Targets Ther; 2013; 6():1539-43. PubMed ID: 24204164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon cancer with unresectable synchronous metastases: the AAAP scoring system for predicting the outcome after primary tumour resection.
    Li ZM; Peng YF; Du CZ; Gu J
    Colorectal Dis; 2016 Mar; 18(3):255-63. PubMed ID: 26400111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.
    Li Z; Lin S; Jiang T; Wang J; Lu H; Tang H; Teng M; Fan J
    Int J Clin Exp Pathol; 2014; 7(10):6462-74. PubMed ID: 25400724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer.
    Lopez-Guerra JL; Verdugo-Sivianes EM; Otero-Albiol D; Vieites B; Ortiz-Gordillo MJ; De León JM; Praena-Fernandez JM; Marin JJ; Carnero A
    Oncotarget; 2015 Oct; 6(30):30343-56. PubMed ID: 26327509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer.
    Sánchez-Velázquez P; Pera M; Jiménez-Toscano M; Mayol X; Rogés X; Lorente L; Iglesias M; Gallén M
    Clin Transl Oncol; 2018 Oct; 20(10):1321-1328. PubMed ID: 29623587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer.
    Fitzgerald TL; Rangan S; Dobbs L; Starr S; Sigounas G
    J Surg Res; 2014 Nov; 192(1):82-9. PubMed ID: 24953984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
    Lou YT; Chen CW; Fan YC; Chang WC; Lu CY; Wu IC; Hsu WH; Huang CW; Wang JY
    PLoS One; 2014; 10(4):e0123973. PubMed ID: 25919688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
    Zhao S; Jiang T; Tang H; Cui F; Liu C; Guo F; Lu H; Xue Y; Jiang W; Peng Z; Yan D
    J Gastroenterol Hepatol; 2015 Apr; 30(4):680-8. PubMed ID: 25238407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.